Biden Administration Releases Revised Guidance For Medicare Drug Price Negotiation Amid Industry Lawsuits
The Centers for Medicare and Medicaid Services released revised guidance on using its authority with pharmaceutical manufacturers in the Medicare Drug Negotiation Program to expand benefits, lower drug costs, keep prescription drug premiums stable, and improve the strength of the Medicare program.…
#centersformedicare #medicaidservices #medicare #cms #hhs #medicareadvantage